FreeIn Brief WHO and St. Jude form $200M collaboration to increase global access to childhood cancer medicines December 13, 2021Vol.47 No.46
Cancer History ProjectConversation with The Cancer LetterFree A book draws on 50 years of accumulated wisdom, calls for “A New Deal for Cancer” December 10, 2021Vol.47 No.45By Paul Goldberg
FreeIn the Archives A commitment to hope: Richard Nixon and the National Cancer Act December 10, 2021Vol.47 No.45
Cancer History ProjectConversation with The Cancer LetterFree What the NCI cancer centers program looked like in 1975Previously unpublished “memos for the record” by program’s first leader, John Yarbro, tell all December 03, 2021Vol.47 No.44By Paul Goldberg
Cancer History ProjectConversation with The Cancer LetterFree Patricia Ganz on how survivorship went from being an outlier to the mainstream November 19, 2021Vol.47 No.43By Alexandria Carolan
FreeIn the Archives Cancer researchers, including Nobel laureates, center directors, gather at Nixon Library to mark 50th anniversary of the National Cancer Act November 19, 2021Vol.47 No.43
FreeHealth Equity Project Equity: FDA considers options to increase diverse enrollment in clinical trials November 12, 2021Vol.47 No.42By Matthew Bin Han Ong
Conversation with The Cancer LetterFreeHealth Equity FDA’s Lola Fashoyin-Aje: Stop getting stuck on the “risks” of diversity in drug development, it’s time to fix disparities in access November 12, 2021Vol.47 No.42By Matthew Bin Han Ong
Conversation with The Cancer LetterFreeHealth Equity NCTN group chairs, experts: Diverse representation of minorities in clinical trials and drug development saves lives November 12, 2021Vol.47 No.42By Matthew Bin Han Ong
